IN2014DN06213A - - Google Patents

Info

Publication number
IN2014DN06213A
IN2014DN06213A IN6213DEN2014A IN2014DN06213A IN 2014DN06213 A IN2014DN06213 A IN 2014DN06213A IN 6213DEN2014 A IN6213DEN2014 A IN 6213DEN2014A IN 2014DN06213 A IN2014DN06213 A IN 2014DN06213A
Authority
IN
India
Prior art keywords
linezolid
isomer
relative
hydroxide
provides
Prior art date
Application number
Other languages
English (en)
Inventor
Sujay Biswas
Atulya Kumar Panda
Ashish Kumar Gupta
Shishupal Singh
Praveen Tiwari
Dharam Vir
Saji Thomas
Original Assignee
Jubilant Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jubilant Life Sciences Ltd filed Critical Jubilant Life Sciences Ltd
Priority to IN6213DEN2014 priority Critical patent/IN2014DN06213A/en
Priority claimed from IN267DE2012 external-priority patent/IN2012DE00267A/en
Priority claimed from IN200DE2012 external-priority patent/IN2012DE00200A/en
Publication of IN2014DN06213A publication Critical patent/IN2014DN06213A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
IN6213DEN2014 2012-01-24 2013-01-22 IN2014DN06213A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN6213DEN2014 IN2014DN06213A (zh) 2012-01-24 2013-01-22

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IN2254DE2012 2012-07-19
PCT/IB2013/050537 WO2013111048A1 (en) 2012-01-24 2013-01-22 Improved process for the preparation of stable crystalline form-i of linezolid, substantially free of residual solvent
IN6213DEN2014 IN2014DN06213A (zh) 2012-01-24 2013-01-22
IN267DE2012 IN2012DE00267A (zh) 2012-01-31 2013-01-22
IN200DE2012 IN2012DE00200A (zh) 2012-01-24 2013-01-22

Publications (1)

Publication Number Publication Date
IN2014DN06213A true IN2014DN06213A (zh) 2015-10-23

Family

ID=47884428

Family Applications (1)

Application Number Title Priority Date Filing Date
IN6213DEN2014 IN2014DN06213A (zh) 2012-01-24 2013-01-22

Country Status (4)

Country Link
US (2) US20150025236A1 (zh)
EP (1) EP2852580A1 (zh)
IN (1) IN2014DN06213A (zh)
WO (1) WO2013111048A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108117527A (zh) * 2018-01-12 2018-06-05 上海龙翔生物医药开发有限公司 一种适用于工业化生产的利奈唑胺晶型ⅰ制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY115155A (en) * 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
US5688792A (en) 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
SK284703B6 (sk) 1996-04-11 2005-09-08 Pharmacia & Upjohn Company Spôsob prípravy substituovaných oxazolidinón alkoholov
KR100580408B1 (ko) 1997-11-07 2006-05-16 파마시아 앤드 업존 캄파니 엘엘씨 옥사졸리디논의 제조 방법
AR027261A1 (es) 2000-02-02 2003-03-19 Upjohn Co Linezolid forma cristalina ii
US6444813B2 (en) 2000-02-02 2002-09-03 Pharmacia & Upjohn Company Linezolid-crystal form II
AU2003278592A1 (en) 2003-10-16 2005-04-27 Symed Labs Limited A novel crystalline form of linezolid
CA2602073A1 (en) 2005-02-24 2006-08-31 Teva Pharmaceutical Industries Ltd. Processes for the preparation of linezolid intermediate
WO2009032294A2 (en) 2007-09-06 2009-03-12 Teva Pharmaceutical Industries Ltd. Processes for the preparation of a linezolid intermediate, linezolid hydroxide
WO2009063505A2 (en) * 2007-10-08 2009-05-22 Usv Limited Process for preparation of (s) (n-[[3-[3-fluoro-4-(4-morpholinyl) hen l -2-oxo-5-oxazolidin l methyl]acetamide
WO2010084514A2 (en) 2009-01-02 2010-07-29 Neuland Laboratories Ltd. A process for the preparation of (5s)-(n)-[[3-[3-fluoro-4-(4-morpholinyl) phenyl]-2-oxo-5-oxazolidinyl] methyl] acetamide
WO2011050826A1 (en) * 2009-10-28 2011-05-05 Synthon B.V. Process for making crystalline form a of linezolid
WO2011077310A1 (en) 2009-12-26 2011-06-30 Alembic Limited Process for the preparation of linezolid
WO2011114210A2 (en) 2010-03-15 2011-09-22 Jubilant Life Sciences Limited Processes for the preparation of linezolid
WO2014013498A1 (en) * 2012-07-17 2014-01-23 Symed Labs Limited Amorphous coprecipitates of linezolid

Also Published As

Publication number Publication date
US20170066728A1 (en) 2017-03-09
US20150025236A1 (en) 2015-01-22
WO2013111048A1 (en) 2013-08-01
EP2852580A1 (en) 2015-04-01

Similar Documents

Publication Publication Date Title
MX2013006926A (es) Compuestos y composiciones fotocromicas.
NZ739757A (en) Processes for preparing jak inhibitors and related intermediate compounds
NZ600119A (en) Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives
NZ626505A (en) Substituted pyrrolidine-2-carboxamides
UA110354C2 (uk) Противірусні сполуки
IN2014MN01521A (zh)
MX350211B (es) Proceso para la preparacion del etil-ester del acido n- (4-ciclohexil-3-trifluoro-metil-benciloxi) -acetimidico.
MX340125B (es) 2-hidroxi-4-(metiltio) butironitrilo estable en almacenamiento.
EP2590649A4 (en) PROCESS FOR SYNTHESIS OF SUBSTITUTED MORPHINANES
IN2014DN10617A (zh)
BR112014004523A2 (pt) composto e composição aromatizante
IN2014DN00144A (zh)
IN2014MN00976A (zh)
IN2013MU03442A (zh)
WO2013190455A3 (en) Process for the preparation of lurasidone hydrochloride
MX342273B (es) Proceso para la preparacion de esteres de acido (5-fluoro-2-metil-3-quinolina-2-ilmetil-indol-1-il)-acetico.
WO2014087208A3 (en) A process of preparing alcaftadine
BR112015015880A2 (pt) processo para a produção do composto, composto de fórmula, preparação farmacêutica e compostos, composições, métodos e utilizações substancialmente inovadores
IN2014DN06213A (zh)
WO2018125983A8 (en) Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (acmsd) inhibitors
EP4282973A3 (en) Processes for the preparation of pyrimidinylcyclopentane compounds
JO2812B1 (en) A method of obtaining the aggregate V crystal form of agomelatine
MX2013004193A (es) Procedimiento para la preparacion de derivados de acido 3-(6-amino-piridin-3-il)-2-acrilico.
NZ711329A (en) A process for preparation of (2s, 5r)- sulfuric acid mono-{ [(4-aminopiperidin-4-yl) carbonyl]-7-oxo-1,6-diaza-bicyclo[3.2.1]-oct-6-yl} ester
EA201201293A1 (ru) Гидрат гидробромида агомелатина и его получение